Relevance and practicability of internal mammary sentinel node biopsy for breast cancer

Breast Cancer

Volumn 9, Issue 4, 2002, Pages 329-336

  Noguchi, Masakuni ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Breast cancer; Internal mammary lymph node; Sentinel lymph node

Indexed keywords

BREAST TUMOR; FEMALE; HUMAN; INJECTION; LYMPH NODE; LYMPH NODE METASTASIS; METHODOLOGY; PATHOLOGY; PROGNOSIS; REVIEW; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; FEMALE; HUMANS; INJECTIONS; LYMPH NODES; LYMPHATIC METASTASIS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 0036371193     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967613     Document Type: Review

References (52)

1. Giuliano AE, Kirgan DM, Guenther JM, and Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401, 1994. (Pubitemid 24313232)
2. Krag DN, Weaver O J, Alex JC, and Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-340, 1993. (Pubitemid 24019852)
3. Albertini JA, Lyman GH, Cox C, Yeatman T, Balducci L, Ku NN, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, and Reintgen DS: Lymphatic mapping and sentinel node biopsy in the patients with breast cancer. JAm Med Assoc 276:1818-1822, 1996.
4. Noguchi M: Sentinel lymph node biopsy and breast cancer. BritJ Surg 89:21-34, 2000.
5. Veronesi U and Valagussa P: Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 47:170-175, 1981. (Pubitemid 11167377)
6. Veronesi U, Marubini E, Mariani L, Valagussa P, and Zucali R: The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomized trial. Eur J Cancer 35:1320-1325, 1999. (Pubitemid 29397430)
7. Veronesi U, Cascinelli N, Greco M, Bufalinot L Morabito A, Galluzzo D, Conti R, De Lellis R, Donne VD, Piotti P, Sacchini V, Clemente C, and Salvadori B: Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202:702-707, 1985. (Pubitemid 16229385)
8. Noguchi M, Ohta N, Koyasaki N, Taniya T, Miyazaki I, and Mizukami Y: Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Cancer 68:1918-1925, 1991.
9. Noguchi M: Comment on "Improved axillary staging of breast cancer with sentinel lymphadenectomy". Ann Surg 225:126-127, 1997.
10. Noguchi M: Internal mammary sentinel node biopsy for breast cancer: Is it practicable and relevant? Oncol Rep 9:461-468, 2002.
11. Noguchi M, Tsugawa K, and Miwa K: Internal mammary chain sentinel lymph node identification in breast cancer.J Surg Onco1 73:75-80, 2000. (Pubitemid 30123729)
12. Noguchi M: Unresolved issues in internal mammary sentinel lymph node biopsy for breast cancer. Breast Cancer 9:91-94, 2002.
13. Cserni G and Szekeres JP: Internal mammary lymph nodes and sentinel node biopsy in breast cancer. Surg Oncol 10:25-33, 2001. (Pubitemid 33086837)
14. Noguchi M, Koyasaki N, Ohta N, Kitagawa H, Earashi M, Thomas M, Miyazaki I, and Mizukami Y: Internal mammary nodal status is more reliable prognostic factor than DNA ploidy and c-erbB-2 expression in breast cancer patients. Arch Surg 128:242-246, 1993. (Pubitemid 23057653)
15. Cody HS and Urban JA: Internal mammary node status: A major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 2:32-37, 1995.
16. Morrow M and Foster RS: Staging of breast cancer: A new rationale for internal mammary node biopsy. Arch Surg 116:748-751, 1981. (Pubitemid 11107339)
17. Veronesi U, Cascinelli N, Bufalino R, Morabito A, Greco M, Galluzzo D, Donne VD, Lellis DR, Piotti P, Sacchini V, Conti R, and Clemente C: Risk of internal mammary lymph-node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 198:681-684, 1983. (Pubitemid 14202741)
18. Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, and Lavin PT: The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 131:301-308, 1996. (Pubitemid 26078817)
19. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen M-B, and Zedeler K: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337:949-955, 1997. (Pubitemid 27425950)
20. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, Wilson KS, Knowling MA, Coppin CML, Paradis M, Coldman AJ, and Olivotto IA: Adjuvant radiotherapy and chemotherapy in node-positive premenopansal women with breast cancer. N Engl J Med 337:956-962, 1997. (Pubitemid 27425951)
21. Overgaard M, Jensen M-B, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blicher-Toft M, and Mouridsen H: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353:1641-1648, 1999. (Pubitemid 29224519)
22. Ragaz J, Jackson SM, Le N, Manji M, Wilson K, Olivotto I, Coldman A, and Spinelli J: Postmastectomy radiation outcome in node positive breast cancer patients among N1-3 versus N4+ subsets: impact of extracapsular spread. Update of the British Columbia randomized trial. Proc Amer Soc Clin Oncol 18:73, 1999.
23. van der Ent FWC, Kengen RAM, van der Pol HAG, Povel JACM, Stroeken HJG, and Hoofwijk AGM: Halsted Revisited: Internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 234:79-84, 2001. (Pubitemid 32619338)
24. Paganelli G, De Cicco C, Cremonesi M, Prisco G, Calza P, Luini A, Zurrida P, and Veronesi U: Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med 42:49-53, 1998. (Pubitemid 28244267)
25. Noguchi M: Sentinel lymph node biopsy in breast cancer: An overview of the Japanese experience. Breast Cancer 8:184-193, 2001.
26. Krag DN, Ashikaga T, Harlow SP, and Weaver DL: Development of sentinel node targeting technique in breast cancer patients. Breast J 4:67-74, 1998. (Pubitemid 28176432)
27. Harlow S, Krag D, Weaver D, and Ashikaga T: Extraaxillary sentinel lymph nodes in breast cancer. Breast Cancer 6:159-165, 1999.
28. Borgstein PJ, Meijer S, and Pijpers R: Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 349:1668-1669, 1997. (Pubitemid 27234813)
29. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, Cicco CD, Geraghty JG, Luini A, Sacchini V, and Veronesi P: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349:1864-1867,1997. (Pubitemid 27270119)
30. Linehan DC, Hill AD, Akhurst T, Yeung H, Yeh SDJ, Tran KN, Borgen PI, and Cody HS HI: Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 6:450-454, 1999. (Pubitemid 29379562)
31. Roumen RMH, Valkenburg JGM, and Geuskens LM: Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oneo1 23:495-502, 1997. (Pubitemid 28059771)
32. Klimberg VS, Rubio IT, Henry R, Cowan C, Colvert M, and Korourian S: Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 6:860-865, 1999. (Pubitemid 30191736)
33. Kern KA: Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 189:539-545, 1999.
34. Roumen RMH, Geuskens LM, and Valkenburg JGH: In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Onco1 25:347-351, 1999. (Pubitemid 29364218)
35. Tanis PJ, Nieweg OE, Olmos RAV, and Kroon BB: Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Surg 192:399-409, 2001. (Pubitemid 32208882)
36. Burak WE, Walker MJ, Yee LD, Kim JA, Saha S, Hinkle G, Olsen JO, Pozderac R, and Farrar WB: Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg 177:445449, 1999.
37. McMasters KM, Wong SL, Turtle TM, Carison DJ, Brown M, Noyes RD, Glaser RL, Vennekotter D J, Turk PS, Tate PS, Sardi A, and Edwards MJ: Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 231:724-731, 2000. (Pubitemid 30249834)
38. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, and Renwick SB: Mammary lymphoscintigraphy in breast cancer. J Nucl Med 36:1775-1780, 1995.
39. O'Hea BJ, Hill ADK, El-Shirbiny AM, Yeh SDJ, Rosen PP, Coit DG, Borgen PI, and Cody HS III: Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 186:423-427, 1998. (Pubitemid 28169364)
40. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, and Beitsch P: The sentinel node in breast cancer. A multicenter validation study. New EngI J Med 339:941-946, 1998. (Pubitemid 28455095)
41. Noguchi M, Tsugawa K, Miwa K, Yokoyama K, Nakajima K, Michigishi T, Minato H, Nonomura A, and Taniya T: Sentinel lymph node biopsy in breast cancer using blue dye with or without isotope localization. Breast Cancer 7:287-296, 2000.
42. Nieweg OE, Jansen L, Olmos RAV, Rutgers EJT, Peterse JL, Hoefnagel KA, and Kroon BBR: Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med 26(Suppl):Sll-S16, 1999.
43. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EFI, Boom RPA, van Diest PJ, and Teule GJJ: Impact of lymphoscinfigraphy on sentinel node identification with Technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38:366-368, 1997. (Pubitemid 27376884)
44. Winchester D J, Sener SF, Winchester DP, Perlman RM, Goldschmidt RA, Motykie G, Martz CH, Rabbitt S, Brenin D, Stull MA, and Moulthrop JM: Sentinel lymphadenectomy for breast cancer: Experience with 180 consecutive patients: Efficacy of filtered technetium 99m sulfur colloid with overnight migration time.JAm Coll Surg 188:597-603, 1999.
45. Gulec SA, Moffat FL, Carroll RG, and Krag DN: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-coUoidal albumin in breast cancer. Nucl Med 38:366-368, 1997.
46. Johnson N, Soot L, Nelson J, Franzini D, Vea H, Gruner S, Kulawiak L, and Young K: Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg 179:386-388, 2000. (Pubitemid 30621647)
47. Dupont EL, Salud CJ, Peltz ES, Nguyen K, Whitehead GF, Ku NN, Reintgen DS, and Cox CE: Clinical relevance of internal mammary node mapping as a guide to radiation therapy. Am J Surg 182:321-324, 2001. (Pubitemid 33079079)
48. Lucci A Jr, Kelemen PR, Miller CIII, Chardkoff L, and Wilson L: National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 192:453-458, 2001. (Pubitemid 32289065)
49. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, and Krasne DL: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 180:700-704, 1995.
50. Matsuno S: Studies on the metastasis of breast cancer to lymph nodes. II. Diagnosis of metastasis to internal mammary nodes using radiocolloid. Acta Med Okayarna 28:361-371, 1974.
51. Noguchi M, Michigishi T, Nakajima K, Koyasaki N, Taniya T, Ohta N, and Miyazaki I: The diagnosis of internal mammary node metastases of breast cancer. Int Surg 78:171-175, 1993. (Pubitemid 23192289)
52. Noguchi M, Taniya T, Kumaki T, Ashikari A, and Miyazaki I: Breast cancer and regional lymph node dissections. Int Surg 74:180-184, 1989. (Pubitemid 19247538)